Viewing Study NCT05532059


Ignite Creation Date: 2025-12-24 @ 3:03 PM
Ignite Modification Date: 2025-12-31 @ 12:32 AM
Study NCT ID: NCT05532059
Status: RECRUITING
Last Update Posted: 2025-02-10
First Post: 2022-08-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Lenvatinib, Tislelizumab Plus Gemcitabine and Cisplatin (GPLET) in Patients with Advanced Cholangiocarcinoma
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module